Ownership and insider activity for IRIDEX Corporation (IRIX): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically engineered for glaucoma treatment.
Price
| Price | $0.61 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-10 | Dizon Romeo R | P-Purchase | 5,100 | $3K |
| 2026-08-24 | Dizon Romeo R | P-Purchase | 5,368 | $4K |
| 2026-08-24 | Dizon Romeo R | P-Purchase | 1,300 | $973 |
| 2026-07-10 | Mercer Patrick | A-Award | 100,000 | |
| 2026-07-10 | Mercer Patrick | A-Award | 200,000 | $220K |
| 2026-07-10 | Mercer Patrick | A-Award | 100,000 | |
| 2026-07-10 | Dizon Romeo R | A-Award | 170,000 | $187K |
| 2026-07-10 | Dizon Romeo R | A-Award | 30,000 | |
| 2026-07-07 | Novel Inspiration International Co., Ltd. | J-Other | 111,997 | |
| 2026-06-13 | Dizon Romeo R | F-InKind | 2,691 | $3K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.7M | $21.7M | $21.2M | $12.7M | $11.6M | $23.9M | $13.9M | $7.0M | $2.4M | $6.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $10.0M | $7.9M | $9.1M | $9.3M | $7.3M | $9.7M | $9.8M | $9.7M | $8.4M | $9.5M |
| Inventory | $11.6M | $9.4M | $8.8M | $8.2M | $5.7M | $7.6M | $10.6M | $9.9M | $10.8M | $7.9M |
| Total Current Assets | $45.9M | $39.5M | $39.6M | $30.6M | $25.4M | $42.3M | $35.8M | $27.4M | $23.6M | $25.3M |
| Property, Plant & Equipment | $1.5M | $1.4M | $1.2M | $3.5M | $1.9M | $3.0M | $2.1M | $3.0M | $1.9M | $826000 |
| Goodwill | $533000 | $533000 | $533000 | $533000 | $533000 | $965000 | $965000 | $965000 | $965000 | $965000 |
| Intangible Assets | $132000 | $116000 | $100000 | $84000 | $68000 | $2.2M | $2.0M | $1.6M | $1.3M | $984000 |
| Total Assets | $48.1M | $41.6M | $41.7M | $34.8M | $28.0M | $48.7M | $42.3M | $34.4M | $29.1M | $29.2M |
| Accounts Payable | $2.0M | $1.7M | $2.5M | $2.6M | $1.1M | $2.8M | $3.9M | $4.5M | $7.0M | $5.4M |
| Short-term Debt | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | $1.7M | 0 |
| Total Current Liabilities | $8.5M | $10.4M | $11.1M | $9.8M | $8.7M | $12.6M | $12.5M | $13.0M | $16.6M | $13.2M |
| Long-term Debt | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | $1.0M | $3.7M |
| Total Liabilities | $9.0M | $11.1M | $11.7M | $12.1M | $10.6M | $25.4M | $25.1M | $24.9M | $27.0M | $24.2M |
| Retained Earnings | -$16.1M | -$29.0M | -$41.8M | -$50.6M | -$56.9M | -$62.2M | -$69.7M | -$79.0M | -$88.0M | -$92.4M |
| Total Equity | $39.2M | $30.5M | $30.0M | $22.7M | $17.4M | $23.3M | $17.2M | $9.5M | $2.1M | $4.9M |
| Total Debt | 0 | 0 | 0 | $3.2M | $4.2M | $2.7M | $1.8M | $2.7M | $4.6M | $4.5M |
| Net Debt | -$23.7M | -$21.7M | -$21.2M | -$9.4M | -$7.4M | -$21.2M | -$12.2M | -$4.3M | $2.3M | -$1.5M |
| Working Capital | $37.4M | $29.1M | $28.5M | $20.8M | $16.7M | $29.6M | $23.3M | $14.5M | $7.0M | $12.0M |
Financial Health
| Debt / Equity | 1.10 |
| Current Ratio | 1.82 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -1.93 |
Profitability
| Return on Equity | -78.94% |
| Return on Invested Capital | -19.53% |
| Return on Assets | -13.01% |
| Gross Margin | 36.23% |
| Operating Margin | -5.39% |
| Net Margin | -6.88% |
Related companies: ADGM · ALUR · ASBP · COCH · HOTH · IINN · NVNO
Explore sector: Healthcare · Medical - Devices
More sections of IRIX: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks